【摘 要】目的：探讨无抽搐电休克治疗(MECT)对首发躁狂症患者治疗的疗效及安全性。方法：选取本院68例首发躁狂症患者开展研究，标本纳入时间为2018年11月-2019年12月，随机分为参照组和观察组，各34例。分别实行常规药物治疗和无抽搐电休克治疗，对比治疗成效。结果：观察组的BRMS评分低于参照组，且和参照组相比，觀察组治疗有效率相对较高，差异均具有统计学意义(P<0.05)。结论：在对首发狂躁症患者所进行的治疗中，无抽搐电休克治疗能够降低患者的BRMS评分，提高治疗效果。

    【关键词】无抽搐电休克治疗;无抽搐电休克治疗;安全性

    Abstract：Objective To investigate the efficacy and safety of MECT in the treatment of first-episode mania.Results the BRMS score of the observation group was lower than that of the reference group， and the treatment efficiency of the observation group was higher than that of the reference group， the difference was statistically significant (P < 0.05). Conclusion in the treatment of the first manic patients ......